CClinicalTrials.gg
CompletedNCT05104151Updated Nov 2, 2021

Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite

An interventional study of Nutritional bar and Healthy Habits Intervention in Overweight or Obesity, sponsored by CES University. Completed at 1 site in Colombia. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-02.

Sponsored by CES University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years after the study started (first participant enrolled Oct 2017, registered Oct 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

The main objective of the trial is to measure the efficacy of a nutritive bar, in the reduction of weight, body fat and the control of appetite, in patients with overweight and obesity. It will be a randomized single-blind design conducted in 40 subjects.

Read the detailed description

Primary objective and outcome: Difference in body fat percentage and summation of the absolute value of 7 body folds

Secondary objectives and outcomes:

  • Characterize demographically and clinically the population participating in the research study.
  • Determine the differences in body weight between the study groups.
  • Determine the median of minutes of appetite onset in each of the groups. Design: The proposed study is a randomized, single-blind, paralell, single center study. Number of subjects: The number of subjects will be 40. At the start of the study, subjects will be randomly assigned to 2 different groups. All participants will have a evaluation with a nutritionist for an anthropometric assessment that includes the measurement of percentage of fat, sum of body folds, weight, height and Body Mass Index. All participants will receive a nutritional intervention providing a caloric deficit of 500 calories, depending on their daily requirements,and they will be prescribed moderate physical activity from 60 to 90 minutes daily. Participants will then be randomly assigned to gruop A: the nutritional bar group or group B: Control. Participants in group A will be instructed to consume the nutritional bar as an integral part of the previously established caloric regimen so as not to increase the number of prescribed calories and will be instructed to consume the product twice a day during the whole study, approximately 2 to 4 hours after breakfast and 2 to 4 hours after lunch, without additions of other foods or beverages, during consumption, may only be accompanied with water. Participants in group B will be instructed to consume a nutritious snack corresponding to the amount of calories provided by the bar, 2 to 4 hours after breakfast and 2 to 4 hours after lunch. The nutritional intervention will be carried out for 8 weeks for both groups, during the forth week and during the eight week of the intervention, a new nutritional assessment will be carried out with the same protocol of the first evaluation, by a nutritionist to all participants.
02

Conditions studied

  • Overweight or Obesity

Keywords

  • protein
  • weight control
  • appetite
  • overweight and obesity
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.

This study's enrollment of 40 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

CES University is the lead sponsor of 28 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Overweight or obesity (BMI range between 25.0 and 35 kg per m2 and
  • Percentage of fat ≥28 for women and ≥20 for men

Exclusion criteria

Exclusion Criteria:

  • Pregnant
  • People with gastrointestinal, thyroid, renal, hepatic or cardiovascular diseases.
  • Diabetics or hypertensive.
  • People with eating disorders.
  • Use of anti-obesity drugs in the last 4 weeks.
  • Use of nutritional or medicinal anti-obesity supplements in the last 4 weeks.
  • Celiac Disease.
  • Allergies to peanuts, nines, eggs, milk or products derived from milk.
  • Vegans.
  • Physical or mental disability.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Group with nutritional bar

    Participants will recieve two nutritional bars per day during eight weeks, and will receive a healthy habits intervention wich includes: nutritional intervention providing a caloric deficit of 500 calories, and a prescription of moderate physical activity from 60 to 90 minutes daily.

    Dietary Supplement: Nutritional bar · Behavioral: Healthy Habits Intervention

  • Active comparator
    Group without nutritional bar

    Participants will receive a healthy habits intervention wich includes nutritional intervention providing a caloric deficit of 500 calories, and a prescription of moderate physical activity from 60 to 90 minutes daily during eight weeks.

    Behavioral: Healthy Habits Intervention

Interventions

  • Dietary supplementNutritional bar

    Protein-based nutritional bar, providing 155 calories per bar

  • BehavioralHealthy Habits Intervention

    The participants included, will receive a nutritional intervention providing a caloric deficit of 500 calories, depending on their daily requirements, these daily requirements calculated according to the formula BMR (Basic Metabolic Rate). Also prescription of moderate physical activity from 60 to 90 minutes daily will be made.

06

What researchers measure

Primary outcomes

  1. Difference in body fat percentage

    The difference in changes of corporal body fat will be measured by calculating the percentage of body fat and the summation of the absolute value of 7 body folds. The percentage of body fat will be determined by using the Siri equation (% Fat = 4.95 / Dc) - 4.50 x 100), the calculation of the body density by the Jackson and Pollock anthropometric equation Dc = 1.10938 - 0.0008267 (sum of three folds) + 0.0000016 (sum of three folds) 2 - 0.0002574 years), the body folds for this outcome will be performed according to the International Society for the Advancement of Cineanthropometry (ISAK) protocol, with the body adipometer Harpenden (In women: Triceps, supraspinal and anterior thigh) (in men: pectoral, abdomen and thigh).

    Time frame: These measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant

Secondary outcomes

  1. Difference in body weight

    The subjects will be weighed by means of a balance SECA 813

    Time frame: This measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant

  2. Determine the median of minutes of appetite onset in each of the groups.

    The level of appetite after consumption of the food will be evaluated using an analogue visual scale (AVE). The AVE for appetite ranges from "0" (least appetite) to 10 (maximum appetite or hunger) and will be printed on sheets that will be delivered to the participants on the day of their nutritional evaluation and also by email, in case the lose Participants will be asked to either consume the product for group A or the isocaloric food recommended by the nutritionist for group B for two moments in the day (mid-morning or second feeding of the day and during the mid-afternoon or the fourth meal of the day), the subjects will be asked to write in the format the time of food intake, then the subjects must complete the EVA appetite scale every half hour for 2 hours. write by text message to the researchers the time of food consumption, so that they remind participants to fill out the form every 30 minutes.

    Time frame: These levels will be measured over two days over the course of week one of the study for both groups

  3. Difference in summation of the absolute value of 7 body folds

    The body folds for this outcome will be performed according to the International Society for the Advancement of Cineanthropometry (ISAK) protocol, with the body adipometer Harpenden, the 7 body folds will be (triceps, biceps, subscapular, abdominal, supraspinal, anterior thigh and middle leg), and then will be made the summation of the absolute value of these 7 body folds

    Time frame: This measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant

07

Study locations

1 site
  • CES University
    Medellín, Antioquia 050001, Colombia
08

References and documents

Individual participant data

Plan to share: Undecided — IPD will not be shared because the privacy of the participants will be guaranteed by not divulging their names in the scientific study process, or publication.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05104151
Lead sponsor
CES University
Responsible party
Uriel Palacios (MD, CES University) — Principal investigator
First posted
Nov 2, 2021
Start date
Oct 20, 2017
Primary completion
Jun 13, 2021
Completion
Jul 27, 2021
Last update
Nov 2, 2021

Study contacts

Uriel Palacios, MD
principal investigator · Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion